Multiple Myeloma Awareness Month
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell important for a healthy immune system. Over time, myeloma cells collect in the bone marrow, forming tumors in many of the body’s bones. These tumors may keep the bone marrow from making enough healthy blood cells and weaken the bone.
While the causes of multiple myeloma are not fully understood, it is more common in older people, especially men, and African Americans. Some common symptoms include bone pain, weakness or fatigue, weight loss, frequent infections, and frequent urination.
The National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) Program estimates that more than 32,000 people living in the United States were diagnosed with multiple myeloma in 2019 and that nearly 13,000 died of the disease.
March is Multiple Myeloma Awareness Month.
On February 13, 2020, the U.S. Food and Drug Administration (FDA) and the American Association for Cancer Research (AACR) hosted a day-long workshop examining under representation of African Americans in multiple myeloma clinical trials. Learn more in this post from the AACR’s blog, Cancer Research Catalyst.
In October 2020, AACR will present a special conference on the topic of multiple myeloma, Myeloma and Plasma Cell Dyscrasias, gathering the top researchers in the field.